Navigation Links
Manmohan Singh to Inaugurate Rural Water Supply and Sanitation Conference

New Delhi, Prime Minister Dr. Manmohan Singh will inaugurate a two-day conference on rural drinking water supply and sanitation here on Wednesday.

The conference will focus on ensuring sustainability in drinking water supply projects and sanitation for all in the rural areas of the country by 2012.

The conference will broadly focus on the issues, such as, progress under Bharat Nirman, issues of sustainability and convergence, water quality surveillance programme, data management and use of technology for planning and sanitation for all by 2012 with focus on aged, especially abled and children and solid and liquid waste management.

Effective implementation of the drinking water component in Bharat Nirman, the flagship programme of the Government of India, state-specific action plans under Accelerated Rural Water Supply Programme (ARWSP), ARWSP (DDP), sub mission on quality control and the national quality and surveillance programme will also be reviewed.

The total sanitation campaign and the Nirmal Gram Puraskar will also be taken up for discussion and review under rural sanitation.

The usage of web based integrated management information systems developed by the department of drinking water supply for all future programmes will be key to the review process.

Development Minister Raghuvansh Prasad Singh, Water Resources Minister Saifuddin Soz and Ministers of State for Rural Development Chandra Sekhar Sahu and Suryakanta Patil will attend the conference.


'"/>




Page: 1

Related medicine news :

1. Prime Minister Manmohan Against Incentive-Based Population Control
2. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
3. Manmohan Calls for Statistical Reforms in Healthcare and Education
4. Manmohan Singh to Meet UN Chief, Discuss Climate Change
5. Arjun Singh In Hospital After Chest Pains
6. Medical Students Go On A Strike Over Quota System; Demand To Meet Arjun Singh
7. Budhia Singh - Youngest Athlete To Be Dope Tested?
8. Arjun Singh Softens Stand on Quota But says Reservation Irrevocable
9. V P Singh Proposes Doubling Of Medical Seats
10. Marathon Boy Budhia Singh Facing Cash Crunch
11. Maninder Singh Hospitalised After Suicide Attempt
Post Your Comments:
(Date:7/25/2008)... Though the number of jobs created...al companies reported a different kind of slowdown...ous months. , Seattle, WA...s created in the medical field slowed in June over... kind of slowdown that will be music to the ears o...
(Date:7/25/2008)...cKesson Corporation Executive, Robert J. Reilly, J.../ -- Aethon Inc.,( http://www.aethon.com ), the le...pply chain logistics, today announced that Robert ...esident -- Chief Financial Officer., Reilly, who ...r for,McKesson Corporation,s Specialty Pharmacy Di...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:People With GERD More Likely to Develop Asthma 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3
...a common fear in women that their sexual performan..., an international journal of obstetrics and gynec...irth affects a woman's sexual function in the long... women who had given birth for the first time. The...
...inia Tech researcher Stefan Duma has been named as...rs for his biomechanics innovations.// Technology...mechanical engineering and founding director of th...ury Biomechanics, to the 2006 'TR35' list of the t...
... publisher John Wiley & Sons, Inc., confirms their...AASLD for providing subscriptions of their journal...c., had announced on the 6th of September their pl... American Society for Paediatric Gastroenterology,...
...chers at St. Louis Children's Hospital and Washing...e requested authorities not to allow children unde...ATVs). This call was issued after a 10-year review...perience or training in driving motorized vehicles...
Other Medicine News:Health News:A young scientist recognized for biomechanics innovations 2Health News:A young scientist recognized for biomechanics innovations 3Health News:Call To Ban Use Of ATVs By Children 2
(Date:7/23/2008)...ewswire/ -- The following was,released by the U.S....g Member Smith, and Members of the Committee.,Than...e I appeared before this Committee almost six mont...the talented and dedicated professionals,at the Ju...have come to,appreciate that much more deeply thei...
(Date:7/23/2008)...Body Have Greater Concentrations of,Stem Cells, A...wire/ -- Fat removed,from the lower abdomen and in...xcellent source of stem cells, with higher stem ce...ports a Brazilian-based study in August,s,Plastic ...l journal of the,American Society of Plastic Surge...
(Date:7/23/2008)...all/ -- Dendreon Corporation,(Nasdaq: DNDN ) toda...onitoring Committee (IDMC) to review in October 20...ng to the Company,s Phase 3 IMPACT (IMmunotherapy,...as D9902B) clinical trial,of PROVENGE(R) (sipuleuc...ctive cellular immunotherapy for the treatment of ...
(Date:7/22/2008)...swire-FirstCall/ -- Following a,thorough review th...harmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) to...hase 3 study in liver cancer. Progen confirmed,its...olio of compounds and,the company will actively se...es through Merger & Acquisition activity., The st...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Study finds recent trend of growing US disparities in health not inevitable 12680 1Study finds recent trend of growing US disparities in health not inevitable 12680 2Study finds recent trend of growing US disparities in health not inevitable 12680 3Krill discovered living in the Antarctic abyss 2314 1Krill discovered living in the Antarctic abyss 2314 2Pharsight to Present at eClinical Forum 12678 1Pharsight to Present at eClinical Forum 12678 2HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 1HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 2HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 3HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 4HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 5HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 6HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 7HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 8HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 9HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 10HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 11HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 12HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 13HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 14HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 15HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 16HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 17HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 18HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 19HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 20HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 21HealthSouth Reports Results for Fourth Quarter Ended December 31 2007 12674 22
...nspire,Pharmaceuticals, Inc. (NASDAQ: ISPH) today ...al trial comparing epinastine nasal,spray and plac...or,the primary endpoint of improvement in total na...ved in the trial, with the higher,dose (0.1%) achi...ty L. Shaffer, Ph.D., Inspire,s President and CEO,...
...tCall/ -- ISTA,Pharmaceuticals, Inc., today announ....S. Phase II/III clinical study of bepotastine for...dy evaluated two,concentrations of bepotastine, ea...ndpoints of the study were the assessment of,effic... redness.,The preliminary results of the study dem...
Other Medicine Technology:Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 2Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 3Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis 4ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 2ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 3ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 4ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 5